The ACRF is very excited with the quality of the five shortlisted applications for our grants in 2013. Some of the very best researchers in the world feature in these applications.
These final five applications represent a need for more than $20 million in advanced technologies and facilities. They cover many types of cancer, not just one or two.
Our highly esteemed Medical Research Advisory Committee selected these particular projects for further review on two grounds – the world-class standard of the proposed research, and the potential to achieve major breakthroughs in cancer diagnosis, treatment and cure.
That committee, led by Professor Ian Frazer, will now, through a detailed interview process, recommend to our Board the best of the best for ACRF funding. The final awardees will be publicly announced on 13 November this year.
Every dollar we receive in donations this year will go to research that has the power to beat cancer. Please peruse the below, to find out where ACRF donations could be making a difference very soon.
Children’s Cancer Institute Australia, Sydney Application for funding to develop: the ACRF Child Cancer Precision Medicine Centre
This proposal is to establish a fully integrated evidence-based personalised medicine program for children with cancer. The ACRF Centre will offer, for the first time, rationally designed and targeted molecular therapeutics for all child cancer patients who are at high risk of relapse. This centre will provide new treatment options to patients who have not had success with their current treatments.
Queensland Institute of Medical Research, Brisbane Application for funding to develop: the ACRF Centre for Comprehensive Biomedical Imaging
This new centre for biomedical cancer imaging will house advanced technologies with the capability of viewing and measuring biological processes from the molecular through to the anatomical. The equipment will image cancer progression, immune reaction and treatment effects in pre-clinical models, with the ultimate outcome of developing and testing effective therapies to control and defeat cancer.
Children’s Medical Research Institute (CMRI), Sydney Application for funding to develop: the ACRF Telomere Analysis Centre
At the ends of our chromosomes are stretches of DNA called telomeres, which protect our genetic data, make it possible for cells to divide, and influence how we get diseases such as cancer. This proposal will allow an internationally unique consortium of telomere research groups to better understand the differences in telomere biology between normal and cancerous cells. A new ACRF centre at CMRI will facilitate the design of novel anti-cancer drugs that can be used to treat almost all types of cancers. It will become the national telomere testing centre for clinical and diagnostic purposes, and for many collaborative epidemiological studies.
South Australian Health and Medical Research Institute (SAHMRI), Adelaide Application for funding to develop: the ACRF Innovative Cancer Imaging and Therapeutics Facility
This facility will enable the research team to rapidly translate their basic biomedical research discoveries into novel cancer therapies, towards better outcomes and survival for cancer patients. This state-of-the-art facility will house advanced technologies that will provide the tools for researchers to speed up the development of new treatments for cancer.
Victorian Comprehensive Cancer Centre (VCCC), Melbourne Application for funding to develop: the ACRF Translational Proteomics Facility
The aim of this proposal is to create a facility within the VCCC that can undertake, in a translational research setting, complex analysis of proteins and phosphoproteins from human tissue samples to inform pre-clinical cancer drug development and clinical trials. The ACRF Facility will incorporate five emerging technologies with the ability to identify and inform targeted, personalised treatment options for cancer patients.